tiprankstipranks
Trending News
More News >
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
UK Market

Sartorius Stedim Biotech (0RG8) Income Statement

Compare
1 Followers

Sartorius Stedim Biotech Income Statement

Last quarter (Q2 2025), Sartorius Stedim Biotech's total revenue was €745.00M, an increase of 5.46% from the same quarter last year. In Q2, Sartorius Stedim Biotech's net income was €68.50M. See Sartorius Stedim Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.78B€ 2.78B€ 3.49B€ 2.89B€ 1.91B
Gross Profit
€ 1.21B€ 1.23B€ 1.83B€ 1.55B€ 1.00B
Operating Expenses
€ 836.10M€ 749.00M€ 751.70M€ 670.02M€ 499.88M
Depreciation and Amortization
€ 301.70M€ 237.60M€ 181.70M€ 141.56M€ 101.69M
EBITDA
€ 670.50M€ 755.70M€ 1.33B€ 811.96M€ 569.20M
Operating Income
€ 370.60M€ 484.50M€ 995.20M€ 683.30M€ 471.81M
Other Income/Expenses
€ -151.40M€ -83.40M€ 135.20M€ -36.60M€ -11.02M
Pretax Income
€ 219.20M€ 401.10M€ 1.13B€ 646.72M€ 482.63M
Net Income
€ 175.10M€ 309.70M€ 876.10M€ 414.40M€ 335.93M
Per Share Metrics
Basic EPS
€ 1.81€ 3.36€ 9.51€ 4.50€ 3.64
Diluted EPS
€ 1.81€ 3.36€ 9.51€ 4.50€ 3.64
Weighted Average Shares Outstanding
96.78M 92.16M 92.16M 92.18M 92.18M
Weighted Average Shares Outstanding (Diluted)
96.78M 92.16M 92.16M 92.18M 92.18M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History